SCHEMBL11060862

SCHEMBL11060862

C/C(=C\C(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.[Na+]

nearest known ligand 0.64

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.64
IARS1 P41252 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31185688 0.89 HTR2A (0.69) HTR2AIARS1
SCHEMBL11063564 0.85 HTR2A (0.74) HTR2AIARS1
SCHEMBL9372908 0.84 HTR2A (0.59) HTR2AIARS1
SCHEMBL11102671 0.84 HTR2A (0.65) HTR2AIARS1
SCHEMBL11081929 0.83 HTR2A (0.52) HTR2AIARS1
SCHEMBL22972475 0.83 HTR2A (0.59) HTR2AIARS1
SCHEMBL11103148 0.82 HTR2A (0.58) HTR2AIARS1
SCHEMBL26203261 0.82 HTR2A (0.59) HTR2AIARS1
SCHEMBL22972587 0.82 HTR2A (0.59) HTR2AIARS1
SCHEMBL11063266 0.81 HTR2A (0.70) HTR2AIARS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4465689-A MONIC ACID ESTERS BEECHAM GROUP LIMITED (GB) 1984-08-14 US disclosed
US-4318856-A Antibacterial compounds BEECHAM GROUP LIMITED (GB) 1982-03-09 US disclosed
US-4289779-A HETEROCYCLIC ESTERS OF MONIC ACID; TREATMENT OF PENICILLIN-RESISTANT GONORRHEA BEECHAM GROUP LIMITED (GB) 1981-09-15 US disclosed
US-4283411-A MONIC ACID BEECHAM GROUP LIMITED (GB) 1981-08-11 US disclosed
US-4267316-A HETEROCYCLIC ESTERS OF PSEUDOMONIC ACID; UROGENITAL DISORDERS; NEISSERIA; BRONCHIUS; VETERINARY MEDICINE BEECHAM GROUP LIMITED (GB) 1981-05-12 US disclosed
US-4256762-A ESTERS OF MONIC ACID BEECHAM GROUP LIMITED (GB) 1981-03-17 US disclosed
US-4256879-A BACTERICIDES, FURFURYLMETHYL, EPOXYPROPYL BEECHAM GROUP LIMITED (GB) 1981-03-17 US disclosed
US-4237161-A BRONCHITIS AND VENERAL DISEASE BEECHAM GROUP LIMITED (GB) 1980-12-02 US disclosed
US-4235784-A Antibacterial compounds BEECHAM GROUP LIMITED (GB) 1980-11-25 US disclosed
US-4217447-A Antibacterial compounds BEECHAM GROUP LIMITED (GB) 1980-08-12 US disclosed
US-4217448-A MONIC ACID DERIVATIVES BEECHAM GROUP LIMITED (GB) 1980-08-12 US disclosed
US-4166863-A ACTIVE AGAINST HEMOPHILUS AND NEISSERIA BEECHAM GROUP LIMITED (GB) 1979-09-04 US disclosed
US-4102901-A MONIC ACID ESTERS BEECHAM GROUP LIMITED (GB) 1978-07-25 US disclosed